SCHEMBL30730308

SCHEMBL30730308

O=Cc1cc(O)n[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21810960 0.75 HCAR2 (1.00) —
SCHEMBL12500579 0.72 — —
SCHEMBL25429844 0.70 — —
SCHEMBL18985097 0.70 — —
SCHEMBL20168010 0.70 — —
SCHEMBL27766234 0.65 HCAR2 (0.44) —
SCHEMBL4916584 0.65 — —
Hydrochloric Acid SCHEMBL28539580 0.64 HCAR2 (0.42) —
SCHEMBL15728413 0.64 HCAR2 (0.42) —
SCHEMBL17351607 0.64 HCAR2 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562015-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 — — EP disclosed
WO-2024026481-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback